Klinikum der Universitat Munchen

München 81377

1 studies enrolling now · 10 studies all time

What they study most

Active Psoriatic Arthritis, Acute Coronary Syndrome, Cardiovascular Disease, Coronary Artery Disease, Crohn's Disease, Percutaneous Coronary Intervention, Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia, Rheumatoid Arthritis, ST Elevation Myocardial Infarction, Triple Negative Breast Neoplasms, Ulcerative Colitis and Crohn's Disease

Studies at this site

• Study of GS-0151 in Participants With Rheumatoid Arthritis — Recruiting now
• Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — Completed
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI — Completed